发明名称 HYDROXYEICOSENOIC ACID ANALOGS
摘要 A hydroxyeicosenoic acid analog represented by the following Formula (I), th e bond .ident. represents a cis-vinylene group or an ethynylene group; Y represents CH2, O or S(O)p wherein p is 0, 1 or 2; m represents an integer o f 1 to 4 inclusive; n represents an integer of 0 to 3 inclusive; the sum of m and n is an integer of 3 to 7 inclusive; R1 represents a C1-4 alkyl group or a C3-8 cycloalkyl group; R2 represents a hydrogen atom or a methyl group; R3 represents COR4, a nitrile group, a halogen atom, a tetrazole group or a thiazolidinedione group; R4 represents OR6, NHR6, N(OH)R6, NHSO2R5, glycerol or functionalized glycerols; R5 represents a C1-15 alkyl group, a C6-10 aryl group or a C7-14 aryl group substituted with alkyl groups, halogens or amino groups; R6 represents a hydrogen, a C1-10 alkyl group or a C1-10 alkyl group substituted with a hydroxyl group, or a pharmaceutically acceptable salt or hydrate thereof. The compounds of the present invention are useful as an elastase release inhibitor.
申请公布号 CA2460263(A1) 申请公布日期 2003.03.27
申请号 CA20022460263 申请日期 2002.09.09
申请人 TAISHO PHARMACEUTICAL CO., LTD.;BOARD OF REGENTS, THE UNIVERSITY OF TEXAS 发明人 OKUYAMA, SHIGERU;TODA, YOSHIHISA;ONO, NAOYA;CHONAN, TOMOMICHI;HIRANO, HITOMI;MIYATA, NORIYUKI;TANAMI, TOHRU;FALCK, JOHN R.
分类号 C07D277/20;A61K31/047;A61K31/08;A61K31/16;A61K31/18;A61K31/185;A61K31/201;A61K31/231;A61K31/275;A61K31/41;A61K31/426;A61P1/02;A61P1/04;A61P1/16;A61P1/18;A61P7/02;A61P9/00;A61P9/10;A61P11/00;A61P11/06;A61P11/08;A61P13/12;A61P15/00;A61P15/06;A61P17/02;A61P17/06;A61P19/00;A61P19/02;A61P27/02;A61P29/00;A61P31/00;A61P31/04;A61P37/02;A61P37/06;A61P43/00;C07C33/04;C07C33/044;C07C33/42;C07C59/01;C07C59/42;C07C59/46;C07C59/60;C07C69/708;C07C69/732;C07C235/28;C07C255/15;C07C255/16;C07C259/06;C07C309/08;C07C309/10;C07C309/20;C07C309/23;C07C309/24;C07C309/68;C07C311/04;C07C311/17;C07C311/51;C07C317/44;C07C323/52;C07C323/66;C07D257/04;C07D277/34;(IPC1-7):C07C59/00;C07C255/00;C07D277/00;A61K31/42;A61K31/425 主分类号 C07D277/20
代理机构 代理人
主权项
地址